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Abstract— In this review we will cover both clinical and 
technical aspects of the advantages and disadvantages of organ 
specific (dedicated) molecular imaging systems, namely PET and 
SPECT, including gamma cameras. This review will start with 
the introduction to the organ-dedicated molecular imaging 
systems. Thereafter we will describe the differences and their 
advantages/disadvantages when compared with the standard 
large size scanners. We will review time evolution of dedicated 
systems, from first attempts to current scanners, and the ones 
that ended in clinical use. We will review later the state of the art 
of these systems for different organs, namely: breast, brain, 
heart, and prostate. We will also present the advantages offered 
by these systems as a function of the special application or field, 
such as in surgery, therapy assistance and assessment, etc. Their 
technological evolution will be introduced for each organ-based 
imager. 
Some of the advantages of dedicated devices are: higher 
sensitivity by placing the detectors closer to the organ, improved 
spatial resolution, better image contrast recovery (by reducing 
the noise from other organs), and also lower cost. Designing a 
complete ring-shaped dedicated PET scanner is sometimes 
difficult and limited angle tomography systems are preferable as 
they have more flexibility in placing the detectors around the 
body/organ. Examples of these geometries will be presented for 
breast, prostate and heart imaging. Recently achievable excellent 
TOF capabilities below 300 ps FWHM reduce significantly the 
impact of missing angles on the reconstructed images. 
 
Index Terms—Organ dedicated PET, organ specific/dedicated 
SPECT, Nuclear Medicine, compact equipment. 
I. INTRODUCTION 
 
OLECULAR Imaging includes several imaging 
techniques. The main are Positron Emission 
Tomography (PET) [1], Gamma Cameras and Single Photon 
Emission Computed Tomography (SPECT) [2]. These 
imaging modalities are also known as functional imaging 
since they provide information on the biological processes 
occurring in the patient body. Fluorescence imaging can be 
considered as an alternative molecular imaging technique but 
its low penetration range (few millimeters) reduces its 
application field. Other imaging techniques provide 
anatomical or morphological information about the different 
patient’s organs and tissues. The most important anatomical 
imaging techniques are Magnetic Resonance Imaging (MRI), 
Computed Tomography (CT) and Ultrasounds (US). 
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Functional magnetic resonance imaging or functional MRI 
(fMRI) measures brain activity by detecting changes 
associated with blood flow. This technique relies on the fact 
that cerebral blood flow and neuronal activation are coupled. 
Those non Molecular Imaging techniques primarily visualize 
the structure of the organ and, sometimes, its dynamics. These 
data do not provide direct functional metabolic information on 
the tissue status. In contrast, Molecular Imaging provides 
functional organ information. Hybrid imaging systems, 
typically combining molecular and morphologic information 
have been developed and have currently widespread use in 
nuclear medicine departments (PET/CT, SPECT/CT). More 
recently PET/MR has been proposed showing promising 
preclinical and clinical cardiac applications where it could 
play a substantial role [3]. Specific, organ-dedicated, nuclear 
medicine imaging devices could allow one to carry out 
accurate new studies due to a high sensitivity, high spatial 
resolution and high signal-to-noise ratio.  
When dealing with Molecular Imaging (MI) studies 
involving systemic injection of radiolabelled imaging agents 
into the patient, the issue of radiation exposure became 
recently one of the critical aspects associated to nuclear 
medicine. This requires a new radical approach in the future 
developments of Molecular Imaging systems to increase 
sensitivity as much as possible. For that reason, dedicated 
specific systems with modular and optimized geometry, in 
order to attain the highest possible angular coverage of the 
dedicated organ, are desirable. 
   
(a)              (b) 
Fig. 1. Representation of applications using two panels PET, prostate and 
brain imagers, (a) and (b) sketches, respectively. 
In this review we will concentrate on the aforementioned 
PET, SPECT and some Gamma Camera techniques, with 
focus on organ specific designs, also known as dedicated 
systems. See for instance in Fig. 1 sketches for two-panel 
detector approach applied to brain and prostate PET systems. 
One of the aims of this work is to show the reader the 
advantages and disadvantages of organ-dedicated MI systems, 
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especially when compared to large size (whole body) 
scanners. We will describe the technological evolution and 
developments carried out on dedicated clinical systems. We 
will review both the currently existing research and 
commercially available MI devices, as well as future trends. 
The authors would like to point out that in this work it has 
been tried to cite most of the known developments or design 
trends, but most likely some have been, unfortunately and 
non-intentionally, omitted. 
This review is organized with first a brief description and 
basic principles of the most known molecular imaging 
systems, including some history evolution and main 
instrumental components. This is followed by a description of 
these systems applied to different organs, starting from brain, 
to breast and then later to heart. In these sections there are 
descriptions of some of the systems that most have been 
shown in the literature, differentiating them from standard 
gamma cameras, PET, or SPECT systems. There are also 
descriptions of the combinations of these systems with other 
modalities (MR or CT). Later, this review describes other 
organ-dedicated ideas and projects that could benefit early the 
patient, and improve the diagnostic and treatment assessment 
quality available to clinicians.  
II. MI SYSTEMS 
A. Gamma camera 
A Gamma Camera (GC) system employs the lowest number 
of components associated with an MI scanner. Typical designs 
for a GC include a physical heavy metal collimator, a 
scintillation crystal and a photosensor. Other designs are based 
on solid state technology such as Cadmium Zinc Telluride 
(CZT). The earlier GC systems were based on scintillation 
materials but nowadays CZT designs are becoming more 
efficient and also more successfully used. 
In the simpler GC as well as in the tomographic SPECT 
technique, the patient is injected with a single gamma ray 
emitting tracer. The administration method depends on the 
organ and pathology to be examined. Although intravenous or 
intratumoral injections are the most used, in breast cancer also 
peritumoral is used. Gamma rays are emitted from the high 
activity regions in the patient’s body where the imaging agent 
is present, and finding their sources of emission is the key 
objective of MI systems. One of the most used radioisotopes 
in GC is 99mTc, emitting a gamma ray with an energy of 140 
keV. There are specific isotopes with energies of emitted 
gamma rays ranging from 30 to 350 keV. GC designs are not 
typically designed covering the whole energy range, since they 
are optimized for the particular application and the 
radioisotope used. 
Several collimator types are used depending mainly on the 
application, in order to provide position information of the 
points of emission of the gamma rays. Although sensitivity 
and spatial resolution for pinhole collimators significantly 
deteriorates as the source to collimator distance increases, this 
also increases the GC Field of View (FOV). In this sense, for 
applications to small organs, pinhole collimators could be 
desirable in order to increase the FOV at the object plane. The 
hole diameter of the pinhole collimator must be selected as a 
trade off between the spatial resolution, expected distance to 
the imaged object, and the sensitivity of the system. Parallel 
hole collimators, when dealing with organ-dedicated GC do 
not allow to increase the FOV, and although its sensitivity 
does not depend on the source-detector distance and its spatial 
resolution is equivalent to that obtained with pinhole 
collimators, they are more widely used in standard general 
purpose GCs. 
Another widely used type is the multi-pinhole collimator 
based on many pinholes. This last approach is a compromise 
between spatial resolution and sensitivity. Gamma rays going 
through the collimator are stopped in the scintillation or solid 
state material. In the case of the scintillation material, a 
number of visible photons are generated depending on the 
stopped gamma ray energy. Scintillation crystals used in GC 
are NaI, CsI (Na or Tl doped) but also other with higher 
effective atomic numbers such as BGO or GAGG. Gamma 
cameras operate in the so-called single gamma mode and, 
therefore, all these crystals should not contain natural 
radioactivity. The scintillation light is transferred to the 
photosensor element and converted into a measurable signal 
pulse. In the case of CZT detectors, the conversion is directly 
done at the “crystal”. Several photosensor types and 
arrangements have been used and will be described in the 
coming sections. Electronics associated with the treatment of 
the signal pulses make it possible to return an accurate impact 
position within the crystal and, therefore, deduce the point of 
emission.  
First clinical gamma camera designs were possible after the 
development of the Anger scintillation camera concept in 
1957 [4]. Its large detector face was able to capture emitted 
simultaneously gamma emissions from larger areas of the 
body, thus increasing the detection efficiency of gamma 
photons, as compared to the non-imaging gamma probes. 
B. Single Photon Emission Computed Tomography 
SPECT systems are mainly based on multiple GCs mounted 
to a rotation stage and allowing retrieving the tomographic 3D 
information about the imaging agent’s distribution in the body, 
after image reconstruction. Typically, the angular step 
between consecutive single image projections varies from 3 to 
6 degrees, covering all 360 degrees. Similarly to GC, several 
types of collimators, scintillators and photosensors, as well as 
CZT technology are found in SPECT systems.  
In contrast to GC, SPECT provides much more than planar 
projective information as it allows for accurate functional 3D 
information, after the reconstruction process performed by 
dedicated software algorithms. There is a broad variety of 
available radiotracers, making possible a high number of 
SPECT applications such as brain functional studies, heart, 
bone analysis or lung, to name a few. Best known SPECT 
applications in brain imaging are blood perfusion to study 
dementia, epilepsy or TBI (Traumatic Brain Injury). Another 
widely used application of SPECT in brain studies is the use 
of ligand neuroreceptors as imaging agents. SPECT 
technology is used in heart imaging as well, studying the 
myocardium tissue functionality, for example in order to 
discriminate between ischemia and infarct. 
C. Positron Emission Tomography 
The basic detector technology of PET scanners is similar to 
GC. However, no physical collimator is used due to the PET 
coincidence principle with the simultaneous detection of two 
annihilation photons. In PET, patients are injected with a 
positron emitter radiotracer. One of the major factors 
contributing to the acceptance of PET was the development of 
18F labeled 2-fluorodeoxy-glucose (2FDG). In particular, 18F 
emits positrons with an energy nearing 600 keV. Positrons 
annihilates with electrons in the tissue or medium producing 
two approximately back-to-back photons with characteristic 
511 keV energy. Although higher energies than in GC (or 
SPECT) are present in PET, one of the advantages of the 
design is that it needs to be only optimized for a particular one 
energy of 511 keV. In the PET principle, two opposed GC 
type detectors (without physical collimator) measure in 
coincidence the two emitted gamma photons. The line 
connecting the two detected 511 keV conversion  points in the 
two detectors is known as Line of Response (LOR). After a 
complex image reconstruction process, as in the case of 
SPECT, a tomographic emission image is generated. The 
sensitivity in PET is significantly higher by many orders of 
magnitude than in the case of SPECT given the lack of the 
physical collimation. 
PET scanners (also SPECT and GC) must be very sensitive 
in order to fulfill the tracer principle: the molecules that are 
injected in the body should not modify the regular behavior of 
the biosystem. In fact, PET has at least a million fold 
sensitivity advantage over other imaging modalities, for 
instance when imaging studies of metabolism and 
neuroreceptor activity.  
In 1973, Robertson and collaborators built the first PET ring 
scanner but were unable to obtain true reconstructed cross 
sectional images. Phelps and Ter-Pogossian [5][6] published 
the principles of modern PET and their design led to the 
production of the first commercial PET scanner. PET has 
become the technique of choice for static and dynamic 
imaging of biological biomarkers in human patients and in 
animals. 
III. BRAIN IMAGING SYSTEMS 
A. Brain PET 
It is interesting to notice that the first PET scanner was 
already a dedicated brain PET system, proposed by Brownell 
and Aronow in 1952. Brain PET instrumentation has greatly 
evolved from its infancy, when it was used in regional 
localization, to currently providing excellent resolution with 
imaging characteristics that can greatly impact clinical 
management [7]. In this subsection, a review of stand-alone 
PET systems will be carried out first, followed by brain 
imaging implementations using SPECT technology. Last sub-
section is dedicated to brain systems that can sequentially or 
simultaneously be combined with complementary information 
(CT or MRI). 
It was in the 90’s when the High Resolution Research 
Tomograph (HRRT) was launched [8][9], a brain dedicated 
PET. Two prototypes were initially constructed, see example 
photograph in Fig. 2 (a). A double layer prototype consisted of 
five detector heads with two 7.5 mm thick LSO layers and 
three detector heads with an LSO layer and a GSO layer, both 
7.5 mm thick. A single layer prototype had only one layer of 
LSO crystals. The commercial version consisted of eight 
detector heads. Each detector head contains 117 detector 
blocks arranged in a 9 × 13 array which are read out by a 10 × 
14 array of photomultiplier tubes (PMTs). Each detector block 
(19 mm × 19 mm × 20 mm) is cut into 8 × 8 crystal elements. 
The system defines a FOV of 312 mm in diameter and 250 
mm in axial length. A spatial resolution in the range of 2.3 - 
3.2 mm (FWHM) in the transaxial direction and 2.5 - 3.4 mm 
in the axial direction have been reported. Absolute line-source 
sensitivity ranged from 2.5 to 3.3%. Maximum NECR was 45 
kcps and 148 kcps according to the NEMA-2001 and 1994 
protocols, respectively. 
  
(a)             (b) 
Fig. 2. (a) Photograph of the HRRT from [8] ©  Institute of Physics and 
Engineering in Medicine.  Reproduced by permission of IOP Publishing.  All 
rights reserved. (b) Sketch of the Rainbow VHD PET [10]. 
The concept of supine position has been followed by the 
Rainbow VHD PET [10], as shown in Fig. 2 (b). One of the 
particularities of its detector block design is the inclusion of a 
small PMT in the centre between 4 larger PMTs in order to 
better identify the LYSO crystal elements in the gap between 
the large PMTs. The PET ring has a diameter of 463 mm 
aperture and, defines a transaxial and axial FOVs of 256 mm 
and 120 mm, respectively. 
A compact and portable design of a brain scanner has been 
introduced by Brain Biosciences, the so-called CerePET. It 
weighs approximately 23 kg. The device features LYSO 
crystals (2 mm × 2 mm × 13 mm), a bore diameter of 25 cm, 
and a 20 cm axial field-of-view. Preclinical work with 
phantoms showed a spatial resolution in the range from 2 mm 
to 3 mm across the field-of-view with an energy resolution of 
13% [11]. 
A completely new design approach, in which the patient is 
in the upright position, was introduced by Yamamoto, as the 
PET-Hat concept, at the Kobe City College of Technology 
(Japan) [12]. Fig. 3 (a) shows a photograph of the system. The 
detector block design is based on two GSO layers and a 
tapered light guide coupled to a flat panel photomultiplier. The 
tapered light guide is used to increase the size of the GSO 
blocks and reduce the number of PMTs used for the PET. The 
scintillator pixels are 4.9 mm × 5.9 mm × 7 mm for the inner 
layer, but 8 mm thick for the outer layer. Sixteen detector 
blocks are arranged in a 280 mm diameter ring defining a 
transaxial and axial FOV of 200 mm and 48 mm, respectively. 
An energy resolution of the block detectors of about 15% 
FWHM and a timing resolution of 4.6 ns FWHM, were 
respectively determined. Transaxial and axial resolutions at 
the centre of the FOV were reported to be 4.0 mm and 3.5 
mm, respectively, together with a sensitivity of 0.7% at the 
centre of the axial FOV.  
Following the advantages of compact brain PET designs, an 
NIH funded Bran Initiative grant to the AMPET collaboration 
(West Virginia University, UC Davis, Washington University, 
and General Electric GRC, Niskayuna, NY) aims at showing a 
motion free wearable brain PET system [13][14]. It requires 
sophisticated mechanics to permit relatively free and safe 
motion, see Fig. 3 bottom. Self-supported and robot-supported 
ring and helmet type imagers are envisaged. Additional 
challenge is that optimized high efficiency detector designs 
require large coverage and heavier detectors. Here, Silicon 
Photomultipliers (SiPMs) are used to achieve system 
compactness. 
      
   (a)                  (b) 
    
        (c)            (d) 
Fig. 3. Some upright brain PET approaches. (a) PET-Hat design from [12]. (b) 
Upright position of the CareMiBrain (Oncovision). (c)-(d) Portable brain PET 
(AMPET), images courtesy of S. Majewski. 
Measuring and using the photon DOI information has a 
strong image quality impact at the border of the image FOV 
[15]. This becomes more important for compact structures. 
The jPET-D4 PET scanner introduced a four-layer DOI 
scheme achieving high sensitivity and uniform spatial 
resolution [16]. A uniform spatial resolution of 3 mm together 
with a sensitivity of 11.3 ± 0.5% (at the center of the FOV, 
CFOV) is reported. However, about three-fourths of this 
sensitivity is related to multiple-crystals events. The scanner 
has a FOV of 25 cm in diameter [17]. This concept has been 
used for brain imaging following a semispherical geometry 
with even additional detectors located at the patient chin and, 
thus, the geometrical sensitivity for a region-of-interest at the 
center increased by 200%. Compared with standard whole-
body cylindrical PET, the proposed geometries can achieve 
2.6 times higher sensitivity for brain regions [18].  
Providing DOI information is considered one of the 
intrinsic advantages of monolithic crystals. In this sense, a 
stand-alone brain PET system, with the patient also in upright 
position, named CareMiBrain, has been recently proposed, see 
Fig. 3 (b). It has been designed using LYSO blocks of 50 mm 
× 50 mm × 15 mm. The system reaches an axial and transaxial 
FOV of roughly 150 mm and 240 mm, respectively. The 
single LYSO blocks are coupled to arrays of 12 × 12 SiPM, 
but only 16 signals per block are needed to accurately provide 
3D photon impact position [19]. The detectors have shown 
uniform spatial and energy resolutions of 1.8 mm (without 
corrections for the source size used in the measurements, 1 
mm in diameter) and 13%, respectively. Also, a DOI 
resolution of 3.7 mm has been reported. The whole assembly 
is currently under performance evaluation, and a multi-clinical 
research will follow. 
B. Brain SPECT 
Although PET provides the highest sensitivity and allow for 
quantitative measurements, SPECT functional brain images 
reach similar spatial resolutions [2]. The variety of 
radiopharmaceuticals available for brain SPECT is not as great 
as that for PET, however it is expanding rapidly. Recent 
developments make it possible to extract kinetics from 
dynamic SPECT data acquired using detectors that rotate 
while radiopharmaceuticals exchange between biological 
compartments [20]. 
Initial SPECT studies in dynamic brain imaging were 
carried out as early as 1963 [21] using two and, later, four 
discrete detectors [22]. In 1990, SPECT brain imaging was 
realized with a rotating four-headed gamma camera system 
[23]. Also, dedicated brain systems consisting of a ring of 
scintillation detectors were developed [24][25]. These 
included the SPRINT system [24] developed at the University 
of Michigan; the Cleon Brain SPECT system originally 
developed by the Union Carbide Corporation in the 1970s, 
which consisted of 12 detectors that scanned both radially and 
tangentially [26]; ASPECT, a dedicated brain system [27]; and 
the FastSPECT system [28] developed at the University of 
Arizona, which was reported to be able to acquire dynamic 
tomographic data with a sampling interval of 2 s. A system 
with multiple rings of scintillation detectors was also 
developed for brain SPECT studies in Japan by Shimadzu. 
The system consisted of 64 NaI crystals in a 38 cm diameter 
circle [25]. 
Just to mention some brain SPECT systems currently in use, 
the Massachusetts General Hospital (MGH) in Boston has the 
availability for a brain dedicated SPECT [29]. Sensitivity near 
the center of the brain is critical for some clinical applications 
of brain SPECT, especially for those applications which 
require dynamic imaging. This dedicated brain SPECT system 
uses variable focusing to increase the sensitivity for central 
regions of its field of view without compromising spatial 
resolution. The scanner consists of a single ring of NaI crystal 
(internal diameter 31 cm, height 13 cm and thickness 8 mm) 
and, therefore, provides a significant higher sensitivity than 
systems based on multiple heads. The crystal is coupled to 63 
PMT arranged in three contiguous rings [30]. 
C. Multimodal brain imaging systems 
In brain imaging, as in most of other imaging modalities, 
combining functional and anatomical information becomes 
very important, but also technologically challenging. This 
complementary information helps clinicians to better localize 
the lesion under study. The predominant type of anatomical 
and functional imaging combination in brain has been PET 
and CT. Sequential acquisition of both modalities is currently 
possible, but not simultaneous since it is hard to isolate the 
PET electronics from the CT radiation noise. However, in the 
last decade there has been a significant push forward to 
develop simultaneous PET-MRI brain imaging. Note that 
whole-body PET-MRI systems have also been used for brain 
studies [31].  
  
Fig. 4. Photograph of the BrainPET insert, from [34]. 
Commonly known as the first brain PET insert is the one 
developed in Jülich (Germany). The so-called BrainPET was 
combined with the Siemens MAGNETOM Trio MRI 
[32][33][34]. Six 12 × 12 arrays of 2.5 mm × 2.5 mm × 20 
mm LSO crystals are read out by 9 Avalanche Photodiodes 
(APDs). APDs are solid-state photodetector technology, 
working in the avalanche regime. They are sensitive to 
moderate-high temperatures with proportional increase of their 
intrinsic dark counts. Thus, temperature controlled 
environments are preferred for the implementation of these 
systems (see Fig. 4).  
Only few years later, at the department of Electronic 
Engineering of the Sogang University in Seoul, it was 
introduced the first brain PET insert based on SiPMs [35]. The 
system contains 72 detector blocks on a ring structure of 330 
mm aperture (250 mm transaxial and 12.9 mm axial FOV), 
and it reaches 0.33% sensitivity. LYSO crystals of 3 mm × 3 
mm × 20 mm are used. The SiPM signals are transmitted to 
preamplifiers using a 300 cm flexible flat cable. An average 
energy resolution of 18.1±2.1% is reported together with an 
average timing resolution of 4.2±0.2 ns. The spatial 
resolutions of a reconstructed point source ranges from 3.1 to 
6.6 mm, at center and at 10 cm radial offset of the FOV, 
respectively. 
A similar approach was followed at the National Institute of 
Radiological Sciences in Japan, also using SiPMs. A particular 
characteristic of this design is the use of four-layer DOI 
detectors integrated with the head coil of the MRI [36]. SiPMs 
arrays had 4 × 4 readout pixels. LGSO scintillators are 
arranged in 12 × 4 × 4 layers with reflectors inserted between 
them. The size of each crystal element was 2.9 mm × 2.9 mm 
× 5.0 mm. The detector and some electric components are 
packaged in an aluminum shielding box. A birdcage-type RF 
coil is used and simultaneous measurements with no influence 
of the MRI shown. A slight influence of the PET detector on 
the static magnetic field of the MRI was observed near the 
PET detector [37].  
 
(a) 
   
(b)             (c) 
Fig. 5. (a) Sketch of the TRIMAGE approach showing the PET insert ring, RF 
coil and main magnet, from [39]. Bottom, MINDView photographs of the 
PET insert alone (b) and inside an MR installed together with the RF coil (c). 
In 2013 two projects were granted at the European Union 
(EU) to build dedicated brain PET systems, to be MR 
compatible. The TRIMAGE research project develops an 
integrated brain PET-MRI-electroencephalogram (EEG) 
scanner. The MRI has a compact 1.5-T cryogen-free magnet 
and the PET scanner is based on SiPM technology [38]. Two 
LYSO crystal arrays layers with 8 (entrance layer) and 12 mm 
(exit layer) height, and 3.3 mm pixel size will be mounted. 
The inner PET diameter is 31.2 cm and the axial length is 16.7 
cm. Fig. 4 (a) shows design schematics of this system [39]. 
The second research project, named MINDView, is 
developing a PET insert intended to be an upgrade for the 
majority of already globally installed MRI systems [40]. It 
includes a radiofrequency coil that can be connected to any 
regular clinical MR scanner and transform the device into a 
high-resolution PET/MRI hybrid system, see Fig. 4 (b)-(c). 
The PET design is based on LYSO monolithic blocks with 
dimensions of 50 mm × 50 mm × 20 mm, coupled to custom 
SiPM arrays of 12 × 12 elements. These blocks have shown 
capabilities of energy resolution in the 13% range, a DOI 
resolution (FWHM) of 4 mm and a measured spatial 
resolution, on average, of 1.6 mm [41]. The transaxial and 
axial FOV are 240 mm (332 mm aperture) and 150 mm, 
respectively. It has been installed in late 2017 at the nuclear 
medicine department in Klinikum Rechts der Isar (Munich) 
and exhaustively tested inside the Siemens mMR, a whole 
body PET-MR with a 3T main magnetic field. A variety of 
MR sequences for brain imaging (including those for PET 
attenuation correction) have been run, and the PET response 
measured, not showing any performance deterioration. 
Molecular brain imaging is used both in diagnostic 
applications and in therapy assessment. It helps providing 
more accurate information. Recently it has been shown the 
convenience of merging molecular imaging with therapy 
treatments, if possible simultaneously. For instance, at the 
MGH, clinicians have access to a mobile dedicated brain PET-
CT in order to perform better planning of proton therapy, 
among other applications. This particular system makes use of 
SiPM technology for the photosensors, coupled to 2.3 mm × 
2.3 mm × 10 mm LYSO crystal arrays (dual-layers). The 
scanner, as shown in Fig. 6 (a), is mobile and can be 
transported on wheels to any desired location and used with 
any patient bed of adjustable height [42]. 
 
       (a)             (b) 
Fig. 6. (a) PhotoDiagnostic system PET-CT at MGH, this figure was 
originally published in [42]. (b) SPECT, MR-compatible, system called 
INSERT, image courtesy of B. Hutton (UCL). 
Hybrid SPECT-MRI systems require compact detectors that 
include collimation and stationary tomographic acquisitions, 
imposing additional constraints [43]. The main goal of the EU 
project named INSERT is the development of a SPECT 
system to be used as an insert in an MRI gantry, thus enabling 
the simultaneous acquisition of images resulting from the two 
systems. Fig. 6 (b) shows a photograph of that SPECT insert. 
The goal is to achieve similar performance to clinical SPECT 
with a compact design. A static full-ring design based on 
multi-pinhole has been proposed. The novelty of the design is 
found in the shutter mechanism that makes the system very 
flexible and eliminates the need for rotating parts. The target 
spatial resolution of this design is 6 mm [44].  
IV. BREAST IMAGING SYSTEMS 
Worldwide, breast cancer is an important healthcare issue 
that is responsible for significant morbidity, mortality and 
healthcare costs. When breast cancer is diagnosed in its 
earliest states it is a curable disease with a 5-year survival of 
greater than 90% [45]. For breast cancer diagnosis and therapy 
follow-up, whole-body PET devices are currently used. 
However, in addition to its limited spatial resolution and 
system sensitivity, they are bulky and expensive. Moreover, 
each exploration needs about 1 hour to be completed, 
therefore reducing the patient’s throughput. Besides, radiation 
dose injected to the patient is in the range of 250-350 MBq 
(1600 mrem). Current whole-body PET is very sensitive to 
induced background by the radiotracer decays originated in 
the rest of the body, thus reducing breast exploration 
sensitivity. 
Dedicated molecular breast imaging was made possible by 
developments in both fields SPECT and PET. One-side 
gamma cameras of a variety of photosensor types have helped 
radiologists and nuclear medicine physicians since many 
years. 
A. Breast Gamma Camera 
One of the systems introducing planar breast gamma 
imaging is the LumaGEM system (Gamma Medica Ideas Inc.) 
using semiconductor detectors. The camera head is composed 
of a pixelated (12,288 pixels) array of CZT (pixel size 1.5 mm 
× 1.5 mm × 5 mm) detector [46]. The camera head measures 
22.5 cm × 27.7 cm × 6.6 cm. The dead space between the 
outside edge of the head and the active area of the field of 
view is less than 1 cm. The field of view is 20 cm × 15 cm. 
The system is modelled to have an intrinsic spatial resolution 
of 1.6 mm with an energy resolution of <5%, reducing 
scattering radiation in the image data and improving the image 
contrast. 
Based on PSPMT and NaI(Tl) scintillation crystal arrays, 
the Dilon 6800 is a portable planar scintimammography 
gamma camera with 152 mm × 203 mm FOV [47]. It uses 3.2 
mm pitch pixelated crystals.  Three collimators are available: a 
general purpose collimator used primarily for breast imaging; 
a high resolution collimator used for thyroid, gall bladder, spot 
bone and other general nuclear medicine procedures; a Slant-
15 collimator which is used for breast imaging close to the 
chest wall.  It also allows one to carry out biopsy guidance 
using a specific tool. 
A similar concept appeared with the Sentinella, a portable 
gamma camera (1 kg weight) designed for imaging small 
organs and structures of the body, well suited especially for 
surgery scenarios [48]. The equipment is comprised of all the 
elements that allow for the movement of the equipment and 
has the necessary tools for obtaining optimum images for 
diagnostic and surgical purposes. The camera is based on 
CsI(Na) and a flat panel PSPMT. The useful field of view is 
40 mm × 40 mm, with an optimal energy range of 50-200 keV 
(17% energy resolution at 140 keV) and an intrinsic spatial 
resolution of 1.8 mm. 
B. Breast PET 
In the field of PET imaging there have been quite many 
academic and commercial systems worldwide offering high 
performance for molecular breast imaging. High-resolution 
dedicated breast PET scanners have been developed over the 
last 10–15 years, to overcome the limitations of conventional 
PET scanners [49]. These systems can achieve 1.5–2.0 mm 
spatial resolution in the breast, thereby allowing for reliable 
detection of lesions in the 3–10 mm range.  
The PEM Flex, compresses the breast providing 2D images 
similarly to those provided by an X-ray mammography. It has 
2 opposing detectors mounted inside compression breast 
paddles [50], see Fig. 7. The detectors are 6 cm × 16.4 cm in 
imaging area. The detectors scan across the FOV making the 
maximum FOV of the system 24 cm × 16.4 cm. The detectors 
are constructed from 2 mm × 2 mm × 13 mm LYSO crystals 
coupled to PSPMT. A visualization resolution of 
approximately 4 mm diameter objects is possible, if they have 
10 times background activity concentration, and 
approximately 6-7 mm objects if the activity is 4 times the 
background. 
   
Fig. 7. Photographs and design sketch of the PEM Flex system, from [50].  
With the aim of improving imaging lesions near the chest 
wall, it was suggested to have patients in prone position 
together with improved compact detector technology, as it was 
shown with the ClearPEM PET system [51]. This is a two 
panels device with adjustable distance, which can work in two 
modes: mild breast compression with fixed panels, or free 
breast with rotating panels for full tomographic reconstruction. 
One of the most noticeable technical advances of this system 
was the use of APDs, significantly reducing overall detector 
bulkiness, compared to the prior PMT based designs. In more 
detail, each panel holds 96 detector modules. LYSO crystal 
pixels have dimensions of 2 mm × 2 mm × 20 mm. Each side 
of the crystal matrix is optically coupled to a 32-pixel APD 
array for DOI measurements. The spatial resolution of a 
reconstructed small size source varies from 1.4 mm at the 
CFOV to 1.7 mm (transaxial) and 2.6 mm (axial) at 2.5 cm 
from the center. A multimodal version of the ClearPEM has 
also been developed including ultrasound imaging: 
ClearPEM-Sonic [52]. 
At the West Virginia University a similar two-panels 
approach was also implemented, see Fig. 8 (a). It used two 
pairs of rotating detector heads each consisting of an array of 
96 × 72 pixellated LYSO crystals of 2 mm × 2 mm × 15 mm 
coupled to 4 × 3 arrays of PSPMT. The system FOV is 20 cm 
× 15 cm. It reaches about 2 mm spatial resolution in all three-
dimensions, and very high event detection sensitivity (489 
kcps/µCi/mL) [53]. 
A new work on the development of a PET system at the 
Stanford Medical School has been recently published, 
following the two panel concept combined with APD 
photosensor technology, see Fig. 8 (b). Initial applications 
were related to breast imaging, but others such as brain 
imaging are currently suggested [54]. Arrays of 0.9 mm × 0.9 
mm × 10 mm LYSO crystal elements are used. The system 
reaches an active FOV of 16.5 cm × 3.3 cm. High crystal-pixel 
identification is reached, with an energy resolution of 11%, 
but exhibiting a timing resolution of almost 14 ns FWHM, 
most likely due to the use of APD. The 1.2 mm rods in a 
micro-Derenzo phantom are resolved at the CFOV (MLEM 
reconstruction). 
   
(a)            (b) 
  
(c)             (d) 
Fig. 8. (a) Photograph of the breast PET scanner developed at WVU from 
[53]. (b) Sketch of the organ-dedicated PET system suggested at Stanford 
[54]. (c) Photograph showing the MAMMI prototype ring, and (d) showing 
the commercial system with the patient’s arm in adduction, image courtesy of 
Oncovision. 
A breast PET system called MAMMI PET [55] 
(Oncovision) was developed under an FP6 EU grant called 
MAMmography with Molecular Imaging. The system allows 
the patient to lie down in prone position with the breast freely 
hanging down, see photographs in Fig. 8 (c)-(d). The patient’s 
arm on the image breast side is in adduction position helping 
the upper breast quadrant to be also imaged. The opposite arm 
is in abduction position and head tilted to the opposite breast. 
The PET geometry follows a ring shape with 12 (or 24 in the 
case of two rings) detector blocks. It makes use of monolithic 
12 mm thick (50 mm × 50 mm) LYSO crystals, coupled to 
PSPMT, and reaches 1.8 mm spatial resolution at the CFOV 
[56]. The breast length in the axial dimension is covered by a 
step-and-shoot scan process, although the two rings approach 
covers about 80% of the population in one shoot. 
A similar prone approach, but using crystal arrays, was used 
in two Shimadzu designs called O- and C-shaped, respectively 
[57]. The O scanner was designed for imaging patients who 
were in prone position, and the C scanner was designed for 
patients positioned inclined leaning forward, see Fig. 9 (a). 
Both dedicated scanners have DOI detectors consisting of a 4-
layer 32 × 32 Lu1.8Gd0.2SiO5  crystal array of 1.44 mm × 1.44 
mm × 4.5 mm coupled to a 64-channel PSPMT.  
With the aim to reduce system costs, an approach at the 
Washington University, Seattle, makes use of the concept of 
position sensitive sparse sensor arrays for breast (also brain) 
imaging systems [58], see Fig. 9. LYSO crystals of 1.93 mm × 
1.93 mm × 20 mm are well resolved using only a 4 × 4 SiPM 
array. The PET concept follows the idea of a box shape that 
could allocate one or two breasts in prone position. 
    
(a)             (b) 
Fig. 9. (a) Photograph of the C-shape PEM system, this figure was originally 
published in [57]. (b) Sparse detector concept. 
A huge number of studies have been carried out with 
dedicated breast PET systems. Perhaps two of the most 
important applications are its high specificity as well as its 
capability to resolve the tumour heterogeneity. Fig. 10 shows 
on the top row an MR image of two breasts with predicted 
lesions (red-underlined). In parallel, and without crossed 
information, breast PET dedicated images were taken with the 
MAMMI system (bottom row), pinpointing just one lesion 
and, therefore, improving the specificity. A recent EU project 
(HYPMED) is developing a hybrid system of these two 
medical imaging modalities (MRI and PET) for improved 
diagnosis of breast cancer and personalised therapy control 
[59], see system sketch in Fig. 11 (a).  
An extension of the RatCAP (rat conscious animal PET) 
technology from Stony Brook University has been also 
applied in a PET system for simultaneous breast PET-MRI 
imaging [60], see Fig. 11 (b). It has been successfully tested 
with patients. The PET ring is made out by 24 detector blocks 
of LYSO (4 × 8 array of crystals, where each element has a 
size of 2.2 mm × 2.2 mm × 5 mm) and APD arrays. The 
scanner has a maximum inner diameter of 100.8 mm. Using a 
Derenzo-like phantom, 2.4 mm rods were well resolved. 
However, it showed some drawbacks regarding imaging 
lesions that were close to the chest wall. 
 
Fig. 10. Images courtesy of Dr. José Ferrer Rebolleda, Director Médico 
Asistencial, Ascires, Valencia, SPAIN. 
  
   (a)             (b) 
Fig. 11. (a) Realization of the PET-RF coils planned in HYPMED project 
[59]. (b) Photograph of the implementation carried out at Stony Brook 
University, from [60]. 
C. Breast SPECT 
SPECT systems have also been developed for breast 
imaging. A prototype of a combined SPECT–CT was 
developed and evaluated at the Pisa University [61]. The 
SPECT system is based on two scintillator matrices coupled to 
PSPMT. The heads were based on a CsI(Tl) matrix made up 
of 8 × 8 match-like crystals, 2.5 mm × 2.5 mm × 5 mm size. 
Regions of interest of 1 cm3 were imaged with a 10:1 
tumour/background concentration ratio, within an object 
having a diameter of 8 cm. 
A compact SPECT system was designed and evaluated at 
the Duke University [62]. As it has been claimed for other 
molecular imaging systems, it served as a secondary 
diagnostic tool for breast cancer imaging, particularly in cases 
when mammographic findings were inconclusive. It was based 
on a gamma camera having a field-of-view of 13 cm × 
13 cm with arrays of 2 mm × 2 mm × 6 mm NaI(Tl) 
scintillators coupled to PSPMT. It showed an energy 
resolution of about 14% and an overall sensitivity of 
140 cpm/µCi in a [−10%, +15%] energy window. 
The Delft University and MILabs have recently suggested a 
new breast SPECT design concept. The breast is scanned by 
translating focusing multi-pinhole plates and NaI(Tl) gamma 
detectors together in a sequence that optimizes count yield 
from a volume of interest [63]. The system shows an improved 
contrast-to-noise ratio when compared to planar MBI by 12% 
for 4.0 mm lesions, increasing to 92% in a scan that focuses 
on a breast region containing several lesions. 
V. HEART IMAGING SYSTEMS 
Recent decades have seen large decline trend in 
cardiovascular disease (CVD), and coronary artery heart 
disease (CAD) mortality, with rates of CVD mortality falling 
by >30% in both sexes and CAD mortality falling by a third in 
men and over a quarter in women [64]. CVD still remains the 
leading cause of mortality, premature death and morbidity in 
developed countries, causing almost 4.1 million deaths per 
year in the European Union alone. This figure represents 46% 
of all deaths in Europe. The control of CVD (and CAD) risk 
factors in primary prevention is generally poor and 
inadequately controlled [65]. Cardiac imaging has gained 
worldwide acceptance to detect and characterize extent and 
severity of cardiovascular diseases by non-invasive means. 
CAD has been a particular target of new diagnostic 
procedures. Using quantification techniques such as molecular 
imaging, allows one determination of absolute parameters 
providing benefits in several clinical scenarios [66]. Currently, 
the most robust technique to quantify perfusion noninvasively 
in human heart is PET. Technical advances as well as 
preventive measures have resulted in an impressive decline of 
mortality based on coronary artery disease in recent years.  
Since CAD becomes symptomatic during physical activity, 
most diagnostic procedures are linked to exercise procedures. 
Although flow reserve has been shown to be of incremental 
value for prognosis [67], it seems that absolute hyperemic 
myocardial blood blow outperforms myocardial flow reserve 
in the noninvasive diagnosis of functionally relevant CAD. 
These findings pave the way for stress-only protocols, 
obviating the need of resting perfusion imaging. However, 
these physical activities are today limited due to the technical 
requirements of imaging devices (supine position, large 
imaging gantry, motion artifacts…). 
A. Heart PET 
Very recently, some dedicated specific PET systems 
devoted to cardiac studies have been developed (Attrius PET, 
Truesight PET). They are based on large detector structures, 
mainly based on conventional Whole Body (WB) geometries, 
and are not optimized from the sensitivity and resolution point 
of views for the specific organ under study (human heart), see 
Fig. 12. These systems make use of previous generation 
PSPMT technology and crystal arrays. Attrius PET scanner, 
with a weight of 2500 kg, uses 8.5 mm × 9.8 mm × 30 mm 
BGO crystals arranged in 24 rings, 128 pixelated crystals 
each, read out by a total of 768 PMTs. With an axial FOV of 
123.6 mm and a ring diameter of 78 cm, it has a spatial 
resolution of about 5.8 mm and a sensitivity of 200×103 
counts/s/µCi/cc. Using BGO crystal implies a coincidence 
resolving time (CRT) of 6 ns, well above the values obtained 
for LYSO based PET systems, where CRTs of 500 ps are 
nowadays obtained. There is a new version of Attrius scanner 
(Attrius L PET) with 32 rings and an axial FOV of 166 mm, 
thus increasing the sensitivity up to 280×103 counts/s/µCi/cc, 
whit no significant variation on other parameters. Heart 
dedicated specific PET systems with modular and optimized 
geometry in order to attain the highest possible angular 
coverage of the human heart are desirable. 
 
Fig. 12. Truesight cardiac PET system from Neusoft Medical, photograph, 
from http://medical.neusoft.com.        
The design of an ideal heart dedicated PET should consider 
the actual size and position of the human heart in the body, as 
well as to allow patient motion during scan, especially for tests 
under heart stress situation, see Fig. 13. At present, there are 
no imaging techniques that are able to evaluate the functional 
operation of the heart while performing exercise and that 
permit limited movement of the patient. Current protocols 
visualize heart operation under induced stress but not under 
realistic upright exercise conditions. In the cardiac stress test, 
this heart condition is artificially induced through the use of 
stress drugs that are associated with considerable side effects. 
In a design, where a panel PET geometry would be fixed and 
only patient motion is allowed, 3D position markers are 
necessary to transmit patient-PET relative position to the data 
acquisition system for recording and inclusion in the 
reconstruction algorithm [68]. Several reconstruction 
algorithms could be implemented to take into account the 
actual patient position, obtaining the reconstructed image in a 
fixed-like reference frame. In this way, motion artifacts, 
normally present during PET scans (i.e. respiratory motion) 
can be truly monitored and compensated in the final image. 
Considering the dimensions and position of the human heart 
(see also Fig. 13), optimal scanner design should be 
asymmetric, assuring the covered solid angle in the front and 
rear panels is equivalent (Ω1 = Ω2) and, therefore, 
maximizing the sensitivity in the heart location. For typical 
heart dimensions (12 cm in length, 9 cm wide, and 6 cm in 
thickness), sensitivity for a point-like source located at the 
center of the heart position has been reported, using Monte 
Carlo simulation tools, to be about 16.5% (LYSO, 20 mm 
thick) for a front panel of 24 cm × 18 cm and a rear panel of 
48 cm × 36 cm [69]. However, such atypical detector system 
geometry presents special challenges. It requires excellent 
determination of the photons TOF (to overcome the problem 
generated by the limited angle geometry) and DOI (to deal 
with the small detector panel distance that increases the 
parallax error).   
 
(a)             (b) 
  
(c)             (d) 
Fig. 13. (a)-(b) Dedicated heart PET scanners allowing patient movement to 
induce heart stress. (c)-(d) Sketches of a heart dedicated PET scanner, with 
limited angle coverage (dual-panel) to allow patient movement. Typical D 
value is about 9-10 cm, although PET design should allow adjustment of PET 
panel distance. In this way, PET detectors can be placed as close as possible to 
the body in order to maximize sensitivity 
B. Heart SPECT 
Digirad was probably the first company to develop and 
manufacture a dedicated cardiac SPECT scanner (Cardius 3 
XPO) [70]. Although this system was originally designed to 
use CZT pixelated detectors, the production models make use 
of pixelated CsI(Tl) detectors and photodiodes. Each detector 
head is 21.2 cm × 15.8 cm and contains an array of 768 (6.1 
mm × 6.1 mm × 5 mm) crystals coupled to individual silicon 
photodiodes. Data acquisition is typically accomplished in 7.5 
minutes by rotating the patient chair through an arc of 202.5°. 
With this system, the manufacturer reports a reconstructed 
spatial resolution of 15.4 mm and a sensitivity of 234 cpm/µCi 
using the system’s cardiac collimator. New versions of the 
system have small multiple-gamma cameras that rotate to 
obtain sufficient angular sampling along with an x-ray 
transmission system for obtaining an attenuation map for 
attenuation correction. Since then, several dedicated cardiac 
SPECT scanners have been developed such as the CardiARC 
(Lubbock, USA) [70] or C-SPECT (Rush University Medical 
Center, Chicago, USA), [71]). The C-SPECT has a stationary 
C-shaped gantry that surrounds the left-front side of a patient’s 
thorax. The stationary C-shaped collimator and detectors 
system in the gantry provide effective and efficient detection 
and sampling of photon emission. The collimator system is 
based on the “slit-slat” design and the detector assembled from 
many NaI(Tl)-based modules, packed side-by-side 
transversely.  
CardiARC was also originally designed to use arrays of 
CZT crystals as detectors, but the production model currently 
uses 3 curved NaI(Tl) crystals and an array of photomultiplier 
tubes with proprietary digital logic. Collimation is 
accomplished via a thin curved lead sheet with 6 vertical slits. 
During acquisition, the aperture arc rotates to acquire data 
from multiple projections, providing 1280 angular samples in 
0.14° increments over 180º. Reconstructed spatial resolution 
values quoted by the manufacturer range from 3.6 mm at 82 
mm from the aperture arc, to 7.8 mm at 337 mm. 
Several SPECT devices based on CZT solid state detectors 
have been recently introduced on the market that are 
specifically designed for cardiac studies as the D-SPECT 
[68][72] (Spectrum Dynamics) shown in Fig. 14, or NM 530c 
and NM/CT 570c [73] (General Electric). In the D-SPECT 
system, the patient is imaged in a semi-reclining position with 
the left arm placed on top of the camera. This system consists 
of nine pixellated CZT detector arrays mounted in a vertical 
column. Each detector column is composed by an array of 16 
× 64 CZT elements (2.46 mm × 2.46 mm × 5 mm), collimated 
by a parallel-hole tungsten collimator. Each detector column is 
fixed in a mechanical mounting so that data acquisition can be 
accomplished by rotating the columns in synchrony. Spatial 
resolution measurements performed according to NEMA 
specifications via the standard line source geometry have been 
reported by the manufacturer to average 4.36 mm FWHM. 
NM 530c from General Electric combines a multi-pinhole 
collimator block interfaced with a multidetector array of 2.46 
mm × 2.46 mm pixelated CZT modules. The whole system 
detector contains 19 detector heads of 8 cm × 8 cm. Unlike 
traditional pinhole collimation that uses magnification, in this 
system minification is used. In this case the system resolution 
is preserved because of the small pixels and high intrinsic 
resolution of the CZT technology. A sensitivity of 656.8 
c/s/MBq, an energy resolution of 5.4% at 140 keV and a 
central, tangential and radial spatial resolutions of 6.1, 3.1 and 
4.3 mm, respectively, have been reported.  
However, despite recent efforts to obtain PET-like 
quantitative accuracy results from SPECT images 
[74][75][76], PET still has the unique ability to measure 
absolute radiotracer concentrations with much higher 
sensitivity than any other conventional nuclear imaging 
technique [77], allowing the estimation of cardiac metabolism 
from dynamic images after bolus injection of either 15O-water, 
13N-ammonia, 11C-acetate, or 82Rb. However, the main 
disadvantage of PET cardiac tracers is the short half-life of the 
radioisotopes, requiring an onsite cyclotron or a 82Rb 
generator for tracer production. This can be considered as the 
current bottleneck which slows the increase of the cardiac PET 
technology.  
 
(a)             (b) 
Fig. 14. (a) Dedicated cardiac SPECT camera. (b) Sketch of the camera. 
(images from Ref. [78] ©  Institute of Physics and Engineering in 
Medicine.  Reproduced by permission of IOP Publishing.  All rights reserved). 
VI. OTHER DEDICATED SYSTEMS 
The two panels approach, as described above for imaging 
the human heart or the breast, can be applied to some other 
scenarios. Unless large panels are used or the panel-to-panel 
distance is short enough to minimize the limited angle 
geometry, good quality TOF information of the annihilated 
photons is a must to return accurate and quantitative images. 
In Europe, Prostate Cancer (PCa) is the most common form 
of cancer in men, with an incidence rate of 214 cases per 1000 
men, closely followed by lung and colorectal cancer [79]. 
Furthermore, PCa is currently the second most common cause 
of cancer death in men [80]. In addition, since 1985, there has 
been a slight increase in most countries in the number of 
deaths from PCa, even in countries or regions where PCa is 
not common [81]. The most commonly used method for 
imaging the prostate is Trans Rectal Ultrasounds (TRUS). 
However, less than 60% of tumours – usually advanced 
tumours – are visible with TRUS [82]. CT and MRI are not 
reliable enough in the assessment of local tumour invasion 
[83]. Nevertheless, MRI has here several limitations that 
hamper its widespread application in PCa staging: difficulties 
in interpreting signal changes related to post-biopsy 
haemorrhage and inflammatory changes of the prostate, and 
the significant variability amongst radiologists. PET with FDG 
has no role in early diagnosis of PCa because of low and 
heterogeneous utilization of glucose by PCa, and it has a 
limited role in late stage cancers [84].  
One of the EU projects, but not only one, which has boosted 
the exploration of accurate TOF for a similar geometry is the 
ENDOTOFPET-US project. It aimed reaching 200 ps timing 
resolution, corresponding to a spatial resolution of 3 cm along 
the LOR in such dual-head system. A sketch is shown in Fig. 
15 (a) [85]. The main clinical objective is to address image-
guided diagnosis and minimally invasive surgery with a 
miniaturized bimodal endoscopic probe with a millimeter 
spatial resolution [86]. The clinical cases targeted by this 
project are prostate and pancreas tumors. Both organs are 
commonly examined using endoscopic ultrasound procedures 
through natural orifices and could benefit of the molecular 
information from PET images. The external plate is a detector 
of 23 cm × 23 cm composed of 256 elements of 4 × 4 array of 
3 mm × 3 mm × 15 mm LYSO crystals individually coupled 
to a matrix of SiPM [87]. An internal probe was designed and 
composed of a commercial transrectal ultrasound probe. The 
probe hosts a matrix of 18 × 18 LYSO crystals of 0.71 mm × 
0.71 mm × 10 mm, coupled to digital silicon photomultiplier 
(dSiPM). A coincidence time resolution of 212 ± 22 ps has 
been reported. 
   
(a)             (b) 
Fig. 15. (a) Drawing corresponding to the endoscopic PET probe and external 
panel, as suggested by the ENDOTOFPET-US project. (b) Representation of 
the magnification effect, using a PET probe near the imaging object/organ 
surrounded by an external PET. 
Implementation of a small probe with very high 
performance placed near the organ under study, allows one to 
improve the overall system performance, see Fig. 15 (b). 
Efforts in this direction to study PCa have been carried out in 
a collaboration between the University of Michigan and West 
Virginia University [88]. The improvement comes from the 
natural PET geometrical magnification effect, and a schematic 
is shown in Fig. 15 (b). In a similar approach, the so-called 
tandem PET method also shows to be a good solution when a 
high resolution probe is used. The tandem detector system 
consists of one detector with small detector elements (high-
resolution) and another, bigger in size, with larger area 
detector elements (lower-resolution). This solution can 
potentially be used to create a system with high spatial 
resolution in the plane parallel to the detector without 
significantly increasing expense, since the total amount of 
scintillator and electronics is relatively small compared to 
most of the currently high-resolution ring scanners [89].  
Some design attempts have been carried out combining US, 
MRI and PET imaging capabilities, in one compact probe 
[90]. The PET probe is suggested to include small size crystal 
arrays, coupled to SiPM, an MR compatible photosensor. 
Another approach for PET prostate imaging, but intending to 
avoid the use of a probe, by using two panels with an 
asymmetric design is currently under study at the Institute for 
Instrumentation in Molecular Imaging (i3M, Valencia, Spain), 
see details in Fig. 16. The proposed geometry, as well as it 
was described for the heart case, maximizes system sensitivity 
at the prostate location, located at about 2/3 from the 
abdomen-anus distance. Detector electronics with TOF 
capabilities will reduce the image deformation. The design is 
based on monolithic LYSO crystals (50 mm × 50 mm × 15 
mm) with DOI information [19][91]. 
   
(a)             (b) 
Fig. 16. (a) Photograph of a dedicated two-panels PET for prostate cancer 
detection. (b) Simulated prostate and two lesion-sources  (1 mm diameter 
size). The blue bars illustrate the detector panels, not in the exact position. 
VII. FUTURE DEVELOPMENTS, FUTURE IMAGING 
High specificity molecular imaging agents are suggested to 
drive molecules for theranostics. If the molecules bind 
fundamentally to prostate cancer cells (other tumor cases 
would be specifically applicable), they could be used to drive 
the chemotherapy to PCa specific cells, therefore minimizing 
the secondary effects. Thus, there is an indication of 
combining dedicated molecular imaging systems with the 
development of theranostic drugs based on Prostate Specific 
Monoclonal Antibodies (PSMSA) targeting molecular 
imaging agents. 
The application of nanotechnology to medicine is building a 
new scenario for the development of the pharmaceutical and 
biotechnological industry in the coming years [92]. In the 
particular case of cancer chemotherapy, the administration of 
therapeutic molecules and genes has evolved in the last decade 
to the application of synthetic nanodevices as vehicles for the 
intracellular diffusion of drugs [93]. The ultimate objective is 
to develop a system stable in biological fluids, in order to 
carry a significant amount of the therapeutic agent to cancer 
cells with no premature release, and introducing a controlled 
release of the drug through selective interaction with some 
intracellular components [94]. In this new scenario, organ-
dedicated MI devices with increased sensitivity and spatial 
resolution play a crucial role in therapy follow-up and 
theranostics applications. 
The authors can think of many other scenarios where 
dedicated MI systems will soon play an important role. Most 
of the systems described along this review are currently used 
either for diagnostic purposes or, in some cases, for treatment 
assessment. However, it is unlikely that they are used for 
screening or during surgery. One of the drawbacks of those 
two applications, especially when talking about PET, is the 
fact that a radiotracer is needed. That constrains its use for 
screening purposes. Positron emitter radiotracers suitable for 
accurate imaging (low positron energies) are typically only 
obtained in cyclotrons and have short lifetimes, what makes 
them difficult to use if the tests are carried out far from the 
cyclotron place. Improving techniques using high energy 
positron emitters, combined with high performance dedicated 
systems, are necessary. 
Radiation dose to the patient and to the medical team also 
limits a broader use of MI, as for instance during surgery, see 
sketch example of brain surgery guided using PET imaging in 
Fig. 17 (a). Of course, this limitation is also noticeable if 
dedicated systems are not efficient. Therefore, improving the 
physical system sensitivity of the system should be intensively 
investigated in the design of organ-dedicated systems, making 
it possible to reduce administrated doses and, therefore, 
patient and clinicians’ exposures. 
 
(a)             (b) 
Fig. 17. (a) Sketch of a brain PET for surgery with multiple modules placed 
flexibly around the head. (b) Sketch of a two-panels PET during proton 
therapy. 
During surgery, one could imagine placing a PET detector 
panel under the patient back and a second panel (a camera) 
with certain motion freedom, but controlled, on top of the 
patient and with the organ under study in between the PET 
detectors. By moving the free panel and precisely knowing its 
space potion (optical tracking, infrared tracking, etc…), it 
could be possible to reconstruct, at least a part of the FOV in 
between the two detectors. There are currently PET image 
reconstruction methods capable of doing this. 
Other designs for PET systems, mainly devoted for surgery 
applications, try to facilitate the surgeon access to the patient. 
A two panel PET system with a window aperture for tumor 
surgery guidance has been recently proposed [95]. However, 
sensitivity at the center is reduced by a factor of 3 if the open 
window in the center of the panel reaches the 44% of the panel 
area (see sketch in Fig. 18 left). Notice that this design implies 
even less angular coverage that those proposed in Fig. 13 or 
Fig. 16. A single-ring OpenPET enabling PET imaging during 
radiotherapy has also been proposed [96]. The proposed 
geometry has a cylinder shape cut at a slant angle, in which 
the shape of each cut end becomes an ellipse, as shown in Fig. 
18 (b) [97]. In this case, the single-ring OpenPET shows a 
sensitivity 1.2 times higher than the dual-ring OpenPET 
proposed previously by the same authors [98]. Moreover, 
applications such as dose verification by in-beam PET 
measurement during particle therapy and real-time tumor 
tracking by PET require sensitivity focused onto the gap 
produced by the dual-ring OpenPET geometry, just the region 
where this geometry is less efficient.  
Two additional application fields where dedicated 
molecular imaging devices can play an important role are: in 
combination with therapy treatment or biopsy guidance 
assistance. Molecular imaging techniques would be best 
suitable for determining the dose delivered to the target and to 
surrounding tissues as for instance in proton (hadron) therapy, 
Fig. 17 (b) shows a schematic example. To effectively 
integrate a PET into a hadron therapy treatment centre, the 
system falls into the limited angle tomography types scanner. 
This geometry allows the beam to pass through the patient 
without hitting the detectors of the PET scanner. Biopsy 
guiding is typically complex to carry out using molecular 
imaging as for instance in breast or prostate cancer 
procedures. However, a dedicated system would allow one to 
safely and accurately perform these tasks. It would allow real-
time visualization and 3D image reconstruction of tumours, 
monitoring the path of the needle inside the patient [99]. 
  
(a)             (b) 
Fig. 18. (a) Sketch of the PET panel window approach for surgery, from [95]. 
(b) Sketch of the slant approach of the OpenPET scanner [97]. 
Back to the idea of using two panels PET system, such a 
configuration could be extended to almost any organ, if 
accurate TOF information and photon DOI are available. The 
panels could, as described above, make use of optical markers 
to monitor their space position while acquiring data. What 
facilitates this approach is that these days the photodetectors 
are mostly done using compact solid state SiPM technology, 
making the PET system less bulky and, furthermore, MR 
compatible. 
The aforementioned tandem idea could also be combined 
with the existing and installed whole-body PET scanner base 
or even with the newest total-body PET [100]. High precision 
detectors could be placed near the organ under study, and use 
the body PET as the second/coincidence detector. This image 
magnification idea was introduced before [101]. 
A scenario that we would also like to introduce in this 
review, and especially towards the future trends in molecular 
imaging, is the use of these medical techniques in 
rehabilitation care. Particular interest has been put in the 
research of innovative neuro-rehabilitation techniques, 
adapted through portable neuroimaging systems. One of the 
aims is developing portable PET technology, following some 
of the ideas introduced at West Virginia University [14], and 
combine them with Virtual Reality (VR) or/and Augmented 
Reality (AR) in the rehabilitation of stroke or Traumatic Brain 
Injury (TBI), to name but a few. VR is for instance currently 
under use in Alzheimer Disease rehabilitation, see Fig. 19. A 
very low weight PET is needed, thus compromising physical 
sensitivity of the system. An alternative approach is to use 
novel mechanical systems that hold the PET scanner or help 
compensating its weight, such as an exoskeleton. In 
collaboration with the University of Virginia, the authors have 
proposed a complete cylinder of BGO material (see Fig. 19 
left), perhaps covered on the top with an additional block to 
further increase sensitivity [102]. BGO is especially 
interesting for this purpose because of its short attenuation 
length (1.1 cm for 511 keV gamma rays). BGO crystals are 
rather easy to grow, especially when compared to Lutetium-
based fast scintillators (LYSO, LSO). Indeed, the authors have 
recently shown good performance of monolithic BGO blocks 
[103]. Although it has been shown the feasibility of reaching 
high timing resolution capabilities using BGO [104], it is 
widely known that Lutetium-based scintillators or other 
crystals such as LaBr3 or GAGG can provide much better 
timing performances. Using these types of materials will 
definitely improve the TOF resolution and, therefore, increase 
the clinical sensitivity through an improved SNR in the image. 
Thus, smaller volume of scintillation material could be used, 
making it lighter, but with similar overall systemic imaging 
performance. 
 
(a)             (b) 
Fig. 19. (a) Sketch of a brain PET made out of a full scintillation cylinder, VR 
goggles combined. (b) Sketch of a VR platform and a molecular imaging 
device. Sketch provided by S. Majewski (UVa). 
VIII. DISCUSSION 
We have reviewed the varied developed molecular imaging 
systems for organ-dedicated applications. Some of the 
advantages of the organ-dedicated MI systems are their 
improved performance when compared to non-dedicated 
standard MI systems (standard whole body scanners) such as 
image quality and sensitivity both clinical and physical, and 
also their reduced cost. Other advantages arise from small 
footprint and higher patient throughput. Disadvantages of 
organ-dedicated MI techniques are mainly focusing on the 
examination of typically a single organ, reducing their usage 
by different areas or departments in a clinical center. Organ-
dedicated MI systems must accomplish the “point of care”. 
They should, at least, be portable, low cost, provide 
quantitative imaging, and timely feedback. Moreover, when 
dealing with dedicated PET scanners, the drawbacks are 
typically related to their geometry or detectors configuration. 
On one hand, small ring diameters increase the parallax error, 
leading to a degradation of resolution uniformity [105]. 
However, the simultaneous realization of small ring diameters 
and thus high geometric efficiency, together with high spatial 
resolution uniformity can be accomplished with precise 
photon DOI. On the other hand, if partial detector rings are 
used, as for instance two panels geometry, an image quality 
deterioration is expected. Here, the lack of projected angular 
information without a precise determination of the two 
photons time of flight, infers a deformation of the 
reconstructed PET image. Current PET instrumentation trends 
have shown to palliate this effect by providing PET systems 
with accurate photons detection TOF [106]. 
There have been organ-dedicated system developments 
based on different detector block of different designs using 
different types of scintillators and photosensors, following 
evolution of the imaging instrumentation accordingly to their 
introduction to the market [95]. As an example, all initial 
designs of detector blocks started with PMTs, then moved to 
APDs, and now the most common type of photosensor is 
SiPM [107]. We envisage that digital SiPM is potentially the 
most logical evolution way of this technology, but other 
variants may also appear in the field. 
Organ-dedicated molecular imaging systems will definitely 
take advantage of improving timing capabilities in the detector 
blocks design. For any of the applications mentioned above 
not only organ specific, but also assisting in the dedicated 
tasks to be carried out (diagnostic, biopsy, surgery, 
radiosurgery, etc…), providing this additional information, 
will help to improve the image SNR. The benefits are related 
to lowering the dose to the patient (and the clinician) or to 
improve the image quality. As described in the last sections, it 
seems that the multi-panel configuration, starting from two, 
will play a major role in the future of MI dedicated systems. 
Multimodality is another aspect that initial organ-dedicated 
systems lacked. Currently this is not longer the case, and most 
of the developments in this field tend to include multiple 
imaging modalities. 
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